Korean J Obstet Gynecol.  2002 Jan;45(1):117-121.

Effects of an Extract from Cimicifuga racemosa in Menopausal Women

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Dan Kook University, Cheonan, Korea.

Abstract


OBJECTIVE
The aim of the study is to assess the effects of treatment with an extract from Cimicifuga racemosa for 1 year in postmenopausal women with symptoms.
METHODS
In a randomised, open-label, group-comparative study, the change on the Kupperman menopausal index, serum FSH and E2 level, bone densitometry (BMD), and mammographic density by an extract from Cimicifuga racemosa (GYNO-Qx ) (N=40) were compared with an conjugated equine estrogen combined with medroxyprogesterone acetate (CEE/MPA) (N=36) during 12 months in menopausal women.
RESULTS
There were no statistical differences in the change of Kupperman index, serum FSH and E2 level, and mammographic density between two groups after 12 months, except the effect of BMD that the CEE/MPA group (+6.6%) was significantly increased as compared to the extract from Cimicifuga racemosa (+1.1%) baseline.
CONCLUSION
This study suggests that an extract of Cimicifuga racemosa is a safe, effective alternative to estrogen replacement therapy for patients in whom hormone replacement therapy is either refused or contraindicated.

Keyword

Menopause; Cimicifuga racemosa; hormone replacement therapy

MeSH Terms

Cimicifuga*
Densitometry
Estrogen Replacement Therapy
Estrogens
Female
Hormone Replacement Therapy
Humans
Medroxyprogesterone Acetate
Menopause
Estrogens
Medroxyprogesterone Acetate
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr